Used to determine S455 rate (before/after 6 Apr 2026).

Used to determine whether FRS 102 periodic review 2024 changes apply (mandatory for periods beginning on or after 1 January 2026). If blank, year end date is used as a fallback.

S455 will be charged on the closing balance. S455 is refundable once the loan is repaid.

If repaid within 9 months + 1 day of company year end, no S455 is due.

Enter the overdrawn balance at the start of the year. If the DLA was in credit or nil at the start of the year, enter 0 — no S455 or BIK arises on a credit balance.

Balance at the start of the company's financial year, or zero if the loan was first made during this year.

Enter the overdrawn balance at year end. If the DLA is in credit (the company owes the director) or nil, enter 0 — no S455, BIK or disclosure obligations arise on a credit balance.

The outstanding overdrawn balance at your company year end — this drives S455.

Enter the highest month-end closing balance reached during the year. Used to determine if the £10,000 BIK exemption applies and feeds the P11D calculator. Leave blank if same as closing balance. Month-end basis is acceptable — intra-month peaks do not need to be tracked.

Retained profits available for dividend. Used to assess whether a dividend can clear the DLA. Leave blank if unknown.

Balance outstanding at the end of the previous accounting year. Used in the disclosure note comparative column. Leave blank if nil or first year.

Determines the disclosure note wording generated below.

3.75% from 6 Apr 2025. Now reviewed quarterly — check each July, October, January.

Used to calculate the effective CT rate including marginal relief. 19% (≤£50k) · tapered 19–25% (£50k–£250k) · 25% (>£250k). Leave blank to default to 25%.